smartbax In-Licenses Novel Gram-Negative Antibiotic From Aicuris
MUNICH, Germany, January 20, 2026 — smartbax, a biotechnology company focused on next-generation antibiotics, announced the in-licensing of a...
Advertisement
Cogent NDA for Bezuclastinib Advances Under FDA RTOR
WALTHAM, Mass. & BOULDER, Colo., January 20, 2026 — Cogent Biosciences announced that the U.S. Food and Drug Administration...
EMA Validates ENHERTU Combo for First-Line HER2 Breast Cancer
TOKYO and MUNICH | January 19, 2026 — Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency (EMA)...
IRLAB and Biomia Partner to Advance CNS Drug Discovery
GOTHENBURG, Sweden | January 19, 2026 — IRLAB Therapeutics AB, a clinical-stage company focused on novel treatments for Parkinson’s...
FDA Clears BD EnCor EnCompass Breast Biopsy System
FRANKLIN LAKES, New Jersey | January 19, 2026 — Becton, Dickinson and Company (BD) announced that the U.S. Food...
Nxera Reports Positive Phase 3 Results for Daridorexant
TOKYO, Japan and CAMBRIDGE, United Kingdom | January 19, 2026 — Nxera Pharma Co., Ltd. announced positive top-line results...
Concept Life Sciences Appoints Adam Davenport as CSO
CHAPEL-EN-LE-FRITH, United Kingdom | January 19, 2026 — Concept Life Sciences, a leading global contract research organization (CRO) specializing...
FDA Approves First Drug to Delay Heart Failure in Dogs
DULUTH, Georgia | January 19, 2026 — Boehringer Ingelheim announced that the U.S. Food and Drug Administration has granted...
AstraZeneca Secures Global Rights to GPC3 CAR-T Therapy
Rockville, Md. and Shanghai, January 18, 2026 — AbelZeta Pharma, Inc. announced that AstraZeneca has agreed to acquire AbelZeta’s...
Finger-Prick Blood Test Could Enable Early Alzheimer’s Diagnosis
London, January 19, 2026 — Scientists from a major international collaboration led by LifeArc and the Global Alzheimer’s Platform...
Advertisement
